Yatsen Holding Ltd YSG

Healthcare SIC 2844 - Perfumes, Cosmetics & Other Toilet Preparations NAICS Manufacturing › Chemical Manufacturing › Soap, Cleaning Compound, and Toilet Preparation Manufacturing derived NYSE

Last close —
Market cap —
52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2025 figures against the last close

P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-0.01

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue $614.6M$464.9M$481.0M$537.3M$916.4M$802.0M——
Cost of revenue $134.0M$106.3M$127.0M$172.2M$304.6M$286.5M——
Gross profit $480.7M$358.6M$354.0M$365.2M$611.8M$515.6M——
R&D $19.6M$15.0M$15.7M$18.4M$22.3M$10.2M——
SG&A $43.4M$60.9M$70.6M$104.4M$147.7M$328.4M——
Total operating expenses $507.2M$471.6M$482.6M$499.9M$866.7M$926.7M——
Operating income -$26.6M-$113.0M-$128.6M-$134.7M-$254.9M-$411.1M——
Interest expense $5.8M$11.8M$12.5M$5.0M$7.2M$2.2M——
Pre-tax income -$13.2M-$97.7M-$106.1M-$118.7M-$242.9M-$410.9M——
Income tax $15.0K$423.0K$452.0K$392.0K$145.0K$1.1M——
Net income -$11.6M-$97.0M-$747.8M-$118.2M-$241.8M-$411.9M——
EPS, basic -0.01-0.05-0.05-0.05-0.10-0.73——
EPS, diluted -0.01-0.05-0.05-0.05-0.10-0.73——
Shares, diluted (wtd. avg.) 1.86B2.03B2.20B2.37B2.53B833.7M450.5M271.3M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents $109.4M$112.0M$117.9M$219.4M$492.4M$877.7M——
Short-term investments $35.2M$73.9M$171.6M$155.6M————
Receivables $31.6M$29.4M$28.0M$29.1M$55.8M$64.3M——
Inventory $72.7M$52.9M$49.6M$61.4M$109.2M$94.5M——
Total current assets $319.5M$321.6M$415.7M$508.7M$714.9M$1.09B——
Property, plant and equipment $11.0M$10.2M$9.1M$11.0M$38.5M$43.7M——
Goodwill $22.2M$21.2M$78.4M$124.3M$136.4M$3.2M——
Other intangibles $76.9M$76.7M$94.6M$100.0M$117.0M$29.0M——
Total assets $550.1M$544.0M$705.1M$850.0M$1.14B$1.27B——
Accounts payable —$9.9M$14.9M$17.4M$37.8M$71.5M——
Total current liabilities $88.0M$87.7M$86.1M$85.3M$137.7M$173.3M——
Total liabilities $121.0M$118.9M$115.7M$116.0M$198.4M$221.3M——
Retained earnings -$1.16B-$1.10B-$1.03B-$957.0M-$907.3M-$649.8M——
Total equity $430.5M$418.6M$582.4M$684.3M$888.1M$1.05B——

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating cash flow -$13.5M-$33.4M-$15.1M$19.7M-$160.1M-$150.7M——
Depreciation and amortisation $5.3M$5.2M$7.6M$16.5M$20.5M$11.4M——
Capital expenditure $6.0M$7.2M$6.1M$7.4M$22.2M$34.6M——
Investing cash flow $35.3M$81.1M-$36.7M-$167.5M-$232.9M-$78.0M——
Financing cash flow -$21.7M-$54.0M-$48.2M-$94.9M-$267.0K$1.02B——
Buybacks $15.9M$55.6M$30.0M$94.9M$2.4M$75.3M——

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-192038.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -1B -500M 0 500M 1B Revenue, FY2020: 802M Gross profit, FY2020: 515.6M Net income, FY2020: -411.9M Revenue, FY2021: 916.4M Gross profit, FY2021: 611.8M Net income, FY2021: -241.8M Revenue, FY2022: 537.3M Gross profit, FY2022: 365.2M Net income, FY2022: -118.2M Revenue, FY2023: 481M Gross profit, FY2023: 354M Net income, FY2023: -747.8M Revenue, FY2024: 464.9M Gross profit, FY2024: 358.6M Net income, FY2024: -97M Revenue, FY2025: 614.6M Gross profit, FY2025: 480.7M Net income, FY2025: -11.6M FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue — — $802.0M $916.4M $537.3M $481.0M $464.9M $614.6M
Gross profit — — $515.6M $611.8M $365.2M $354.0M $358.6M $480.7M
Net income — — -$411.9M -$241.8M -$118.2M -$747.8M -$97.0M -$11.6M

Others in SIC 2844

TickerCompanyMarket capP/ERevenue growth
CL COLGATE PALMOLIVE CO $74.97B 35.8x 1.4%
EL ESTEE LAUDER COMPANIES INC $39.37B 217.3x 5.0%
KVUE Kenvue Inc. $37.59B 25.8x -2.1%
ELF e.l.f. Beauty, Inc. $6.74B 259.6x 24.6%
IPAR INTERPARFUMS INC $3.69B 22.0x 2.5%
COTY COTY INC. $2.84B — -1.5%
EPC EDGEWELL PERSONAL CARE Co $1.29B 52.9x -1.3%
WALD Waldencast plc $100.3M — -0.7%